Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
Clinical trial NCT04870190 · UNKNOWN
Trial details
- NCT number
- NCT04870190
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2024-06-01
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.